Login | Register

Sector: Life Sciences

Does the impact of Markman orders vary by technology complexity?
Does the impact of Markman orders vary by technology complexity?

Some patent litigators observe that patent disputes involving less complicated technologies tend to settle faster after claim construction. What does Docket Navigator data say?

Three things to know about the US government’s new strategy for standards development
Three things to know about the US government’s new strategy for standards development

Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP

Life Sciences correspondent

Thought leadership from industry experts

Latest updates

EPO Enlarged Board of Appeal confirms use of post-published data to support inventive step
Latest content

Unified Patent Court grants preliminary injunction to 10x Genomics

A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries

19 September 2023

Patent transactions in Q2 2023 soared by 345% YOY

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

15 September 2023

10x Genomics strikes blow against NanoString in the US

IAM explores the American portions of a spat whose UPC and German actions have hogged the limelight

14 September 2023

‘Live or die’: LG Chem prepares to launch series of disputes as strategy pivots, reveals IP head

The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min

13 September 2023

$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

12 September 2023

RegenxBio/Sarepta dispute highlights strategic challenges for gene therapy developers

Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities

08 September 2023

JS Held expands Ocean Tomo IP practice with new acquisition

The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff

07 September 2023

UPC holds first ever preliminary injunction hearing

NanoString Technologies is facing an injunction at the UPC, which has scheduled several further PI hearings in Munich and Vienna

06 September 2023

Delhi High Court clarifies scope of product-by-process claims in landmark pharma ruling

In a first-of-its-kind judgment, the Delhi High Court has refused to grant an interim injunction against the defendants, stating that their process did not infringe the plaintiff’s patent that had constituted a ‘product-by-process’ claim. The patent community is hoping for a more detailed order after the trial, as this will provide much-needed clarity on the scope of product-by-process claims.

06 September 2023

Janssen secures yet more patent settlements with Stelara biosimilars

Here are six key takeaways for patent strategists from the succession of ustekinumab settlements

05 September 2023

Unlock unlimited access to all IAM content

Subscribe Now